Fasudil attenuates disease spreading in ALS - a post-hoc analysis of the ROCK-ALS trial.
medRxiv
2025
Dextromethorphan/quinidine (DMQ) for reducing bulbar symptoms in amyotrophic lateral sclerosis - assessment of treatment experience in a multicenter study.
Amyotroph Lateral Scler Frontotemporal Degener
2026
27
1-2
185-197
Editorial: Innovative approaches to catalyze preclinical and clinical research on amyotrophic lateral sclerosis (ALS) and related disorders.
Front Neurosci
2025
19
Virus-Specific T Cells and Response to Checkpoint Inhibitors in Progressive Multifocal Leukoencephalopathy.
JAMA Neurol
2026
83
3
280-289
Premature skeletal muscle aging in VPS13A deficiency relates to impaired autophagy.
Acta Neuropathol Commun
2025
13
1
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord.
Acta Neuropathol Commun
2025
13
1
Circulating cytokine levels and 5-year vascular recurrence after stroke: A multicenter prospective cohort study.
EUROPEAN STROKE JOURNAL
2026
11
1